🔎 Trials Near Me

Akèy › Kansè fwa (Kasinòm epatoselilè) › Missouri › St. Louis

Etid klinik pou Kansè fwa (Kasinòm epatoselilè) nan St. Louis, MO

13 etid pou Kansè fwa (Kasinòm epatoselilè) ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • Washington University School of Medicine, St Louis
Laj 45 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06995898

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Ap rekriteFaz 1/2
  • Research Facility, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06726161

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Ap rekriteFaz 1/2
  • Siteman Cancer Center, St Louis
  • Barnes-Jewish Hospital, St Louis
  • Washington University School of Medicine - Siteman Cancer Center, St Louis
  • ak 5 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07227012

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

Ap rekrite
  • Siteman Cancer Center Washington University, St Louis
Laj 21 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07824583

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Ap rekriteFaz 3
  • Research Site, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06921785

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Washington University School of Medicine, St Louis
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Washington University School of Medicine, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Ap rekriteFaz 3
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07166406

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

Ap rekriteFaz 1/2
  • Research Site, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT06795022

IDOV-Immune for Advanced Solid Tumors

Ap rekriteFaz 1
  • Washington University School of Medicine, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06910657

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Ap rekrite
  • St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis
Laj 18 a 75 · Tout sèks · Mizajou Jun 17, 2026 · NCT05486572

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Ap rekriteFaz 1/2
  • Washington University in St. Louis, St Louis
Laj 18 ak plis · Tout sèks · Mizajou Apr 27, 2026 · NCT05440708

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, St Louis
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè fwa (Kasinòm epatoselilè) nan lòt vil

Lòt etid nan St. Louis

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.